Home › Funds › Polar Capital Holdings Plc › XENE

Polar Capital Holdings Plc position in XENE

XENON PHARMACEUTICALS INC · Health Care

Polar Capital Holdings Plc reported holding 4,570,556 shares of XENE (XENON PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$275.9M, representing 0.79% of its reported portfolio and ranking #37 among its reported holdings. Polar Capital Holdings Plc has disclosed XENE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.57M sh
Reported value held$275.88M
Portfolio Weight0.79%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Polar Capital Holdings Plc's XENE position evolved

Polar Capital Holdings Plc first disclosed a stake in XENE in Q3 2023 at 3,003,747 shares (US$102.6M). The position peaked in Q2 2026 at 4,570,556 shares, worth US$275.9M. Across 12 filings, Polar Capital Holdings Plc increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,570,556 shares valued at US$275.9M — an increase of 165,244 shares quarter over quarter.. Notable position changes include a 79% increase in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.00M $102.61M New
Q4 2023 3.07M $141.25M Add
Q1 2024 2.61M $112.45M Reduce
Q2 2024 2.54M $98.88M Reduce
Q3 2024 2.44M $96.25M Reduce
Q4 2024 2.70M $105.75M Add
Q1 2025 2.62M $88.00M Reduce
Q2 2025 2.70M $84.61M Add
Q3 2025 2.55M $102.25M Reduce
Q4 2025 2.47M $110.51M Reduce
Q1 2026 4.41M $256.17M Add
Q2 2026 4.57M $275.88M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XENE and 13F data

XENE (XENON PHARMACEUTICALS INC) is a Health Care company. 43 other funds we track also report a position in XENE — the largest reported positions include Avoro Capital Advisors LLC (US$348.7M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$266.7M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$97.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XENE

All XENE fund holders →

FAQ

How long has Polar Capital Holdings Plc held XENE?

Polar Capital Holdings Plc has disclosed XENE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Polar Capital Holdings Plc's current position in XENE?

As of Q2 2026, Polar Capital Holdings Plc holds 4.57M shares of XENE (XENON PHARMACEUTICALS INC), valued at $275.88M, representing 0.79% of its reported portfolio and ranking #37.

Has Polar Capital Holdings Plc been buying or selling XENE?

In the latest 13F filing (Q2 2026), Polar Capital Holdings Plc increased its position in XENE. The position peaked in Q2 2026 at 4.57M shares.

Which other funds hold XENE?

Other major institutional holders of XENE include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.